13,005
Total Claims
$1.8M
Drug Cost
1,333
Beneficiaries
$1,332
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
-13%
Cost per patient vs peers
$1,332 vs $1,524 avg
-17%
Brand preference vs peers
11.3% vs 13.7% avg
Brand vs Generic
89% generic
Brand: 1,472 claims · $1.6M
Generic: 11,533 claims · $188K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 765 | $638K |
| Sacubitril/Valsartan | 205 | $204K |
| Rivaroxaban | 116 | $121K |
| Empagliflozin | 46 | $36K |
| Evolocumab | 37 | $28K |
| Metoprolol Succinate | 1,431 | $23K |
| Ticagrelor | 35 | $17K |
| Potassium Chloride | 711 | $12K |
| Clonidine | 53 | $11K |
| Ranolazine | 115 | $10K |
| Nebivolol Hcl | 155 | $9,686 |
| Atorvastatin Calcium | 710 | $9,093 |
| Clopidogrel Bisulfate | 645 | $8,816 |
| Pitavastatin Calcium | 11 | $8,462 |
| Amlodipine Bes/Olmesartan Med | 138 | $7,124 |
Prescribing Profile
71
Unique Drugs
$999K
Patient Profile
73
Avg Age
61%
Female
1.73
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data